These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 34110010)

  • 1. Pityriasis rosea after mRNA COVID-19 vaccination.
    Abdullah L; Hasbani D; Kurban M; Abbas O
    Int J Dermatol; 2021 Sep; 60(9):1150-1151. PubMed ID: 34110010
    [No Abstract]   [Full Text] [Related]  

  • 2. Pityriasis Rosea Associated With COVID-19 Vaccination: A Common Rash Following Administration of a Novel Vaccine.
    Valk B; Bender B
    Cutis; 2021 Dec; 108(6):317-318. PubMed ID: 35167784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pityriasis Rosea Shortly After mRNA-1273 COVID-19 Vaccination.
    Shin SH; Hong JK; Hong SA; Li K; Yoo KH
    Int J Infect Dis; 2022 Jan; 114():88-89. PubMed ID: 34740803
    [No Abstract]   [Full Text] [Related]  

  • 4. Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine.
    Cyrenne BM; Al-Mohammedi F; DeKoven JG; Alhusayen R
    J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):e546-e548. PubMed ID: 33982814
    [No Abstract]   [Full Text] [Related]  

  • 5. Six cases of pityriasis rosea following SARS-CoV-2 vaccination with BNT162b2.
    Ramot Y; Nanova K; Faitatziadou SM; Assab DA; Berkun Y; Zlotogorski A
    J Dtsch Dermatol Ges; 2022 Aug; 20(8):1123-1124. PubMed ID: 35698860
    [No Abstract]   [Full Text] [Related]  

  • 6. Pityriasis rosea developing after COVID-19 vaccination.
    Marcantonio-Santa Cruz OY; Vidal-Navarro A; Pesqué D; Giménez-Arnau AM; Pujol RM; Martin-Ezquerra G
    J Eur Acad Dermatol Venereol; 2021 Nov; 35(11):e721-e722. PubMed ID: 34237178
    [No Abstract]   [Full Text] [Related]  

  • 7. Pityriasis rosea following SARS-CoV-2 vaccination: A case series.
    Temiz SA; Abdelmaksoud A; Dursun R; Durmaz K; Sadoughifar R; Hasan A
    J Cosmet Dermatol; 2021 Oct; 20(10):3080-3084. PubMed ID: 34363731
    [No Abstract]   [Full Text] [Related]  

  • 8. Post Covid-19 vaccination papulovesicular pityriasis rosea-like eruption in a young male.
    Adya KA; Inamadar AC; Albadri W
    Dermatol Ther; 2021 Sep; 34(5):e15040. PubMed ID: 34165237
    [No Abstract]   [Full Text] [Related]  

  • 9. Maculopapular eruptions following COVID-19 vaccination: Pityriasis rosea or pityriasis rosea-like eruptions?
    Ciccarese G; Mastrolonardo M; Serviddio G; Drago F
    J Cosmet Dermatol; 2023 Sep; 22(9):2380-2381. PubMed ID: 37382032
    [No Abstract]   [Full Text] [Related]  

  • 10. Pityriasis rosea following CoronaVac COVID-19 vaccination: a case report.
    Akdaş E; İlter N; Öğüt B; Erdem Ö
    J Eur Acad Dermatol Venereol; 2021 Aug; 35(8):e491-e493. PubMed ID: 33914958
    [No Abstract]   [Full Text] [Related]  

  • 11. Atypical pityriasis rosea associated with mRNA COVID-19 vaccine.
    Bostan E; Jarbou A
    J Med Virol; 2022 Mar; 94(3):814-816. PubMed ID: 34585750
    [No Abstract]   [Full Text] [Related]  

  • 12. Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature review.
    Wang CS; Chen HH; Liu SH
    J Formos Med Assoc; 2022 May; 121(5):1003-1007. PubMed ID: 35012825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pityriasis rosea-like eruption after Pfizer-BioNTech COVID-19 vaccination.
    Carballido Vázquez AM; Morgado B
    Br J Dermatol; 2021 Aug; 185(2):e34. PubMed ID: 33904157
    [No Abstract]   [Full Text] [Related]  

  • 14. Pityriasis rosea, pityriasis rosea-like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination.
    Drago F; Broccolo F; Ciccarese G
    Clin Dermatol; 2022; 40(5):586-590. PubMed ID: 35093476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manifestation of pityriasis rosea and pityriasis rosea-like eruptions after Covid-19 vaccine: A systematic review.
    Khan I; Elsanousi AA; Shareef AM; Tebha SS; Arif A; Gul S
    Immun Inflamm Dis; 2023 Apr; 11(4):e804. PubMed ID: 37102660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pityriasis Rosea as a Possible Complication of Vaccination Against COVID-19.
    Dormann H; Grummt S; Karg M
    Dtsch Arztebl Int; 2021 Jun; 118(25):431. PubMed ID: 34374333
    [No Abstract]   [Full Text] [Related]  

  • 17. The significance of investigating clinical, histopathologic and virological features in pityriasis rosea and pityriasis rosea-like eruptions following COVID-19 vaccinations.
    Ciccarese G; Parodi A; Drago F
    Dermatol Ther; 2022 Aug; 35(8):e15601. PubMed ID: 35622411
    [No Abstract]   [Full Text] [Related]  

  • 18. Pityriasis rosea like eruption: A dermatological manifestation of Coronavac-COVID-19 vaccine.
    Gökçek GE; Öksüm Solak E; Çölgeçen E
    Dermatol Ther; 2022 Feb; 35(2):e15256. PubMed ID: 34881483
    [No Abstract]   [Full Text] [Related]  

  • 19. Reply to "the significance of investigating clinical, histopathologic and virological features in pityriasis rosea and pityriasis rosea-like eruptions following COVID-19 vaccinations" by Ciccarese G. et al.
    Martora F; Picone V; Battista T; Fabbrocini G; Marasca C
    Dermatol Ther; 2022 Aug; 35(8):e15602. PubMed ID: 35622446
    [No Abstract]   [Full Text] [Related]  

  • 20. Pityriasis rosea, COVID-19 and vaccination: new keys to understand an old acquaintance.
    Busto-Leis JM; Servera-Negre G; Mayor-Ibarguren A; Sendagorta-Cudós E; Feito-Rodríguez M; Nuño-González A; Montero-Vega MD; Herranz-Pinto P
    J Eur Acad Dermatol Venereol; 2021 Aug; 35(8):e489-e491. PubMed ID: 33899974
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.